What is the impact of Brexit on intangible asset structures for UK companies?

Full Explanation

Brexit introduced several practical changes affecting intangible asset structures for UK companies operating in the EU. IP registration: European Union Trade Marks (EUTMs) and Registered Community Designs (RCDs) that previously provided UK protection were automatically cloned into equivalent UK rights — but new EUTM filings no longer cover the UK, requiring separate UK applications. Companies must now maintain parallel UK and EU IP portfolios, increasing registration and maintenance costs. Patent protection was largely unaffected because European Patents (granted by the EPO) are not EU instruments and continue to cover the UK. Transfer pricing: UK-EU intercompany transactions are now cross-border for transfer pricing purposes, potentially requiring more extensive documentation. The UK's exit from EU Parent-Subsidiary and Interest & Royalties Directives means that withholding taxes may apply on royalty payments from EU subsidiaries to UK parent companies (though bilateral tax treaties generally provide relief). IP box regimes: the UK Patent Box (10% rate) continues to operate independently, and the UK is no longer constrained by EU state aid rules in designing IP tax incentives. Regulatory approvals: intangible assets tied to EU regulatory approvals (marketing authorisations for pharmaceuticals, financial services passporting rights) lost their UK validity, requiring separate UK regulatory approvals and potentially creating new intangible assets under UK regulation. Data transfers: restrictions on UK-EU personal data transfers under GDPR required adequacy decisions and contractual safeguards, affecting the valuation of data assets that span both jurisdictions. For PPAs involving UK-EU businesses, these changes affect both the identification of intangible assets (separate UK and EU rights) and their valuation (different useful lives and risk profiles for each jurisdiction).

Related Glossary Terms

Related Questions